Healthcare
CytomX Therapeutics, Inc.
CTMX$3.67+9.23%
Price is delayed.
Add to Watchlist
About CytomX Therapeutics, Inc.
CytomX Therapeutics is a biotechnology company developing experimental cancer drugs. The company focuses on creating antibodies and other proteins that can attack tumor cells while limiting damage to healthy tissue. Most of their drug candidates are still in early testing stages, though they have partnerships with major drugmakers like Amgen, Bristol Myers Squibb, and Moderna to help develop and test these treatments.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore